胸部CT冠状动脉炎症与COVID-19死亡率的关系
该回顾性研究纳入意大利帕尔马大学医院2020年3月和2021年3月收治的769例重症COVID-19住院患者,分析非触发高分辨率胸部CT测量的冠状动脉周围脂肪组织衰减(PCAT)与院内死亡的关系。多因素分析显示PCAT与院内死亡独立相关(p<0.001),而冠状动脉钙化评分无独立关联。
要点
- PCAT可在非触发高分辨率胸部CT上测量,无需对比剂。
- PCAT与重症COVID-19患者院内死亡独立相关(p<0.001)。
- 冠状动脉钙化评分与院内死亡无独立关联。
核心结论
- 非触发高分辨率胸部CT测量的冠状动脉炎症(PCAT)似乎与重症COVID-19患者较高的院内死亡独立相关。
- 校正协变量后,既存的冠状动脉粥样硬化负荷与不良结局无关联。
研究设计与样本
- 回顾性纳入意大利帕尔马大学医院2020年3月和2021年3月收治的COVID-19患者,分别对应意大利第一波和第三波疫情高峰,流行株分别为野生型和B.1.1.7谱系。
- 共纳入769例患者,其中555例(72%)存活出院,214例(28%)院内死亡。
- 收集人口学、临床、实验室、高分辨率胸部CT数据及冠状动脉CT特征(冠状动脉钙化评分和PCAT衰减)。
- 主要终点为院内死亡。
诊断标准与关键数值
- 多因素logistic回归显示年龄(p<0.001)、慢性病数量(p<0.001)、吸烟习惯(p=0.006)、P/F比值(p=0.001)、血小板计数(p=0.002)、血肌酐(p<0.001)、无创机械通气(p<0.001)、高分辨率胸部CT视觉评分(p<0.001)和PCAT(p<0.001)与院内死亡独立相关。
- 冠状动脉钙化评分未显示与院内死亡独立相关。
临床应用与阅片要点
- PCAT可在非触发高分辨率胸部CT上测量,无需对比剂。
- 作者认为,若能在其他研究中得到证实,PCAT或可考虑作为COVID-19患者的独立预后标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The main factors associated with coronavirus disease-19 (COVID-19) mortality are age, comorbidities, pattern of inflammatory response, and SARS-CoV-2 lineage involved in infection. However, the clinical course of the disease is extremely heterogeneous, and reliable biomarkers predicting adverse prognosis are lacking. Our aim was to elucidate the prognostic role of a novel marker of coronary artery disease inflammation, peri-coronary adipose tissue attenuation (PCAT), available from high-resolution chest computed tomography (HRCT) in COVID-19 patients with severe disease requiring hospitalization.
METHODS: Two distinct groups of patients were admitted to Parma University Hospital in Italy with COVID-19 in March 2020 and March 2021 (first- and third-wave peaks of the COVID-19 pandemic in Italy, with the prevalence of wild-type and B.1.1.7 SARS-CoV-2 lineage, respectively) were retrospectively enrolled. The primary endpoint was in-hospital mortality. Demographic, clinical, laboratory, HRCT data, and coronary artery HRCT features (coronary calcium score and PCAT attenuation) were collected to show which variables were associated with mortality.
RESULTS: Among the 769 patients enrolled, 555 (72%) were discharged alive, and 214 (28%) died. In multivariable logistic regression analysis age (p < 0.001), number of chronic illnesses (p < 0.001), smoking habit (p = 0.006), P/F ratio (p = 0.001), platelet count (p = 0.002), blood creatinine (p < 0.001), non-invasive mechanical ventilation (p < 0.001), HRCT visual score (p < 0.001), and PCAT (p < 0.001), but not the calcium score, were independently associated with in-hospital mortality.
CONCLUSION: Coronary inflammation, measured with PCAT on non-triggered HRCT, appeared to be independently associated with higher mortality in patients with severe COVID-19, while the pre-existent coronary atherosclerotic burden was not associated with adverse outcomes after adjustment for covariates.
CLINICAL RELEVANCE STATEMENT: The current study demonstrates that a relatively simple measurement, peri-coronary adipose tissue attenuation (PCAT), available ex-post from standard high-resolution computed tomography, is strongly and independently associated with in-hospital mortality.
KEY POINTS: • Coronary inflammation can be measured by the attenuation of peri-coronary adipose tissue (PCAT) on high-resolution CT (HRCT) without contrast media. • PCAT is strongly and independently associated with in-hospital mortality in SARS-CoV-2 patients. • PCAT might be considered an independent prognostic marker in COVID-19 patients if confirmed in other studies.
引用
- Tuttolomondo D, Ticinesi A, Dey D, et al. Coronary inflammation on chest computed tomography and COVID-19 mortality. Eur Radiol. 2024. PMID: 38221582. doi:10.1007/s00330-023-10573-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。